Aclaris Therapeutics to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Aclaris Therapeutics, Inc. (NASDAQ: ACRS) announced that Dr. Neal Walker, President and CEO, will present at two upcoming virtual investor conferences. The presentations include the H.C. Wainwright Global Life Sciences Conference on March 9, 2021, at 7:00 a.m. ET, and the Oppenheimer 31st Annual Healthcare Conference on March 16, 2021, at 10:00 a.m. ET. Management will also be available for virtual one-on-one meetings on both days. Webcasts of the presentations can be accessed on Aclaris' website and will be archived for 30 days.

WAYNE, Pa., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that Dr. Neal Walker, President and CEO of Aclaris, will present a company overview at the following upcoming virtual investor conferences:

• H.C. Wainwright Global Life Sciences Conference. Tuesday, March 9, 2021 at 7:00 a.m. ET. Management will be available March 9th and 10th throughout the day for virtual one-on-one meetings.

• Oppenheimer 31st Annual Healthcare Conference. Tuesday, March 16, 2021 at 10:00 a.m. ET. Management will be available March 16th throughout the day for virtual one-on-one meetings.
  

A live audio webcast of each presentation may be accessed through the “Events” page of the “Investors” section of Aclaris’ website, www.aclaristx.com. Each webcast will be archived for at least 30 days on the Aclaris website.

About Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation. For additional information, please visit www.aclaristx.com.

Aclaris Contact

investors@aclaristx.com

 

FAQ

When will Aclaris present at the H.C. Wainwright Global Life Sciences Conference?

Aclaris will present on March 9, 2021, at 7:00 a.m. ET.

What is the date for the Oppenheimer 31st Annual Healthcare Conference presentation by Aclaris?

Aclaris will present on March 16, 2021, at 10:00 a.m. ET.

How can I access the Aclaris presentations from the upcoming investor conferences?

The presentations can be accessed via the 'Events' page in the 'Investors' section of Aclaris' website.

Will the Aclaris presentations be available after the live events?

Yes, each webcast will be archived for at least 30 days on Aclaris' website.

Who is the CEO of Aclaris Therapeutics?

Dr. Neal Walker is the President and CEO of Aclaris Therapeutics.